| P2093 | author name string | Y Yarden | |
| | R Pinkas-Kramarski | |
| | H Waterman | |
| | M Sela | |
| | E J van Zoelen | |
| | A E Lenferink | |
| | E Tzahar | |
| | L N Klapper | |
| | M J van Vugt | |
| | M L van de Poll | |
| P2860 | cites work | Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3 | Q24309266 |
| | A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor | Q24648517 |
| | Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 |
| | Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene | Q27860693 |
| | Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation | Q28131755 |
| | SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins | Q28131774 |
| | Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 or HER2 | Q28279061 |
| | Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas | Q28287906 |
| | The MAPK signaling cascade | Q28292599 |
| | Epidermal growth factor-related peptides and their receptors in human malignancies | Q28293442 |
| | Vulval development in Caenorhabditis elegans | Q28305017 |
| | The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4 | Q28513922 |
| | The cellular response to neuregulins is governed by complex interactions of the erbB receptor family | Q28609130 |
| | ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms | Q28609136 |
| | Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions | Q28609149 |
| | ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer | Q28678776 |
| | The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cells | Q28678816 |
| | Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer | Q29547699 |
| | ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling | Q33886341 |
| | Bivalence of EGF-like ligands drives the ErbB signaling network | Q33887274 |
| | Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships | Q34045509 |
| | Cell migration is essential for sustained growth of keratinocyte colonies: the roles of transforming growth factor-alpha and epidermal growth factor | Q34181051 |
| | Monensin interrupts the recycling of low density lipoprotein receptors in human fibroblasts | Q34252494 |
| | Kinase activity controls the sorting of the epidermal growth factor receptor within the multivesicular body | Q34330127 |
| | Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells | Q34353519 |
| | Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis | Q34431223 |
| | Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity | Q35684026 |
| | ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor | Q36653753 |
| | Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes | Q36745372 |
| | Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines | Q37611813 |
| | A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP kinase pathway | Q37634563 |
| | Alternative intracellular routing of ErbB receptors may determine signaling potency | Q38337018 |
| | Characterization of degP, a gene required for proteolysis in the cell envelope and essential for growth of Escherichia coli at high temperature | Q39948895 |
| | The biology of erbB-2/neu/HER-2 and its role in cancer | Q40567924 |
| | Receptor protein-tyrosine kinases and their signal transduction pathways | Q40611453 |
| | A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling | Q40673334 |
| | Endocytosis of growth factor receptors | Q40857015 |
| | Superagonistic behaviour of epidermal growth factor/transforming growth factor-alpha chimaeras: correlation with receptor routing after ligand-induced internalization | Q41044389 |
| | Biological activities of EGF-receptor mutants with individually altered autophosphorylation sites | Q41092861 |
| | Neu differentiation factor/neuregulin isoforms activate distinct receptor combinations. | Q41175866 |
| | Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities | Q41216128 |
| | Receptor-mediated effects on ligand availability influence relative mitogenic potencies of epidermal growth factor and transforming growth factor alpha | Q41225764 |
| | Requirement for neuregulin receptor erbB2 in neural and cardiac development | Q41269625 |
| | Activation of p70/p85 S6 kinase by a pathway independent of p21ras | Q41441452 |
| | The carboxyl terminus of epidermal growth factor receptor/erbB-2 chimerae is internalization impaired. | Q41518562 |
| | The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions | Q41554100 |
| | Biosynthesis of the epidermal growth factor receptor in A431 cells | Q41564487 |
| | The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand. | Q41717039 |
| | The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands | Q41738022 |
| | Ligand-induced transformation by a noninternalizing epidermal growth factor receptor | Q41743656 |
| | Role of acidic intracellular compartments in the biosynthesis of Dictyostelium lysosomal enzymes. The weak bases ammonium chloride and chloroquine differentially affect proteolytic processing and sorting | Q41946234 |
| | Rapid constitutive internalization and externalization of epidermal growth factor receptors in isolated rat hepatocytes. Monensin inhibits receptor externalization and reduces the capacity for continued endocytosis of epidermal growth factor | Q41947153 |
| | Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts | Q42797529 |
| | Identification of the high affinity binding site of transforming growth factor-alpha (TGF-alpha) for the chicken epidermal growth factor (EGF) receptor using EGF/TGF-alpha chimeras. | Q42800534 |
| | Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors | Q42805800 |
| | Engineering epidermal growth factor for enhanced mitogenic potency | Q42806339 |
| | erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells | Q42807469 |
| | Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. | Q42811529 |
| | Transforming growth factor-beta and retinoic acid modulate phenotypic transformation of normal rat kidney cells induced by epidermal growth factor and platelet-derived growth factor | Q42812091 |
| | All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired | Q42816057 |
| | Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with the erbB3 gene product | Q42833317 |
| | Attenuated processing of epidermal growth factor in the face of marked degradation of transforming growth factor-alpha. | Q43513067 |
| | Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor | Q43932368 |
| | A point mutation in the neu oncogene mimics ligand induction of receptor aggregation | Q44611984 |
| | Insulin regulates heregulin binding and ErbB3 expression in rat hepatocytes | Q46371284 |
| | Ligand-induced endocytosis of the EGF receptor is blocked by mutational inactivation and by microinjection of anti-phosphotyrosine antibodies | Q46979793 |
| | Resistance to receptor-mediated degradation of a murine epidermal growth factor analogue (EGF-Val-47) potentiates its mitogenic activity. | Q54311816 |
| | The pathway to signal achievement | Q59067952 |
| | Sequential processing of epidermal growth factor in early and late endosomes of rat liver | Q68293149 |
| | Fusions to staphylococcal protein A | Q68532056 |
| | An exact general analysis of ligand binding displacement and saturation curves | Q70765000 |
| | Coupling of the c-Cbl protooncogene product to ErbB-1/EGF-receptor but not to other ErbB proteins | Q71124118 |
| | A comparison of epidermal growth factor receptor-mediated mitogenic signaling in response to transforming growth factor alpha and epidermal growth factor in cultured fetal rat hepatocytes | Q71673054 |
| | Epidermal growth factor behaves as a partial agonist in hepatocytes: effects on DNA synthesis in primary culture and competition with transforming growth factor alpha | Q71779636 |
| | A single amino acid exchange, Arg-45 to Ala, generates an epidermal growth factor (EGF) mutant with high affinity for the chicken EGF receptor | Q72055027 |
| | Molecular and clinical aspects of the Neu/ErbB-2 receptor tyrosine kinase | Q72771515 |
| | Structural aspects of the epidermal growth factor receptor required for transmodulation of erbB-2/neu | Q73174660 |
| | Intraendosomal degradation of transforming growth factor alpha | Q73195097 |
| | A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors | Q73359246 |
| | Reduced ability of transforming growth factor-alpha to induce EGF receptor heterodimerization and downregulation suggests a mechanism of oncogenic synergy with ErbB2 | Q73932188 |
| | The interaction of an epidermal growth factor/transforming growth factor alpha tail chimera with the human epidermal growth factor receptor reveals unexpected complexities | Q95793023 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3385-3397 | |
| P577 | publication date | 1998-06-01 | |
| P1433 | published in | The EMBO Journal | Q1278554 |
| P1476 | title | Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers | |
| P478 | volume | 17 | |